ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...

The strike began on Tuesday, Oct. 14, and spans hundreds of medical centers and offices in California, Oregon, and Hawaii.

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc.

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Healthcare Trend Analysis Reveals Shift Toward Non-Invasive Pre-Surgical Evaluation as Multi-Modal Compression Technology Addresses Growing Patient Demand for Evidence-Based Alternatives ...

Now, the latest WHO report confirms the growing crisis. It shows that in 2023, one in every six bacterial infections globally ...

A toilet-cleaning pod that doubles as a kidney disease screening device has been shortlisted as a global finalist in the ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...

Colleen Freake of Bramber, N.S., says the drought is affecting her and her partner’s health and mental well-being, as she ...

With this in mind, microbiologist professor Brenda Wilson of the University of Illinois Urbana-Champaign, has shared what you ...

CIABOC, with support from UNDP and the Government of Japan, unveils a transformative platform  In a landmark move to enhance ...